ALAN GLATZ: Open Payments
NPI 1417187659 · BLOOMINGTON, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,631 in 85 payments from 24 companies in 2025. Trend: 2023 $0 · 2024 $1,035 · 2025 $1,631
Food & beverage: $1,546Education: $85
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 12 | $226 |
| Sumitomo Pharma America, Inc. | 15 | $217 |
| Endo USA, Inc. | 9 | $203 |
| Olympus America Inc. | 11 | $148 |
| TOLMAR, INC. | 6 | $112 |
| PROGENICS PHARMACEUTICALS, INC. | 5 | $104 |
| Merck Sharp & Dohme LLC | 5 | $99 |
| ABBVIE INC. | 4 | $76 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $54 |
| Boston Scientific Corporation | 1 | $52 |
Products named: ERLEADA, GEMTESA, XIAFLEX, iTIND System, ELIGARD, PYLARIFY, KEYTRUDA, XTANDI.
Industry payments across IL — which companies pay providers there.
